Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals

This study has been completed.
Fundacio Lluita Contra la SIDA
Hospital Clinic of Barcelona
University of Oxford
Information provided by (Responsible Party):
IrsiCaixa Identifier:
First received: October 4, 2012
Last updated: April 28, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)